POPULUS Health Technologies today announced that Edith Hodkinson has joined as Chief Strategy Officer. Edith brings over 25 ...

Biopharma funding increased for the second consecutive year in 2024. Total large-pharma R&D spending continued to increase. Clinical trial start volumes have stabilized: Trial starts have ...

Fintel reports that on April 10, 2025, Barclays downgraded their outlook for IQVIA Holdings (NYSE:IQV) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 58.50% Upside As of April 2, ...

IQVIA Holdings Inc. provides clinical research ... It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a ...

The market for real-world evidence (RWE) solutions market is expected to grow CAGR of ~10% during the forecast period. The ...

The IQVIA Institute for Human Data Science has released, Global Trends in R&D 2025 report, Progress in Recapturing Momentum ...

Arrowstreet Capital Limited Partnership reduced its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 21.8% in the fourth quarter, according to the company in its most recent 13F ...

and IMS Health (a healthcare data specialist), IQVIA (NYSE:IQV) provides clinical research services, data analytics, and technology solutions to help pharmaceutical companies develop and market ...

Nvidia's healthcare strategy leverages AI to revolutionize medical imaging and diagnostics, according to healthcare GM Kimberly Powell.